What We Are Fighting For.

Mission

The proposed LCD may minimize the likelihood of success for patients at the risk of incurring more complex wounds. This places providers in a position of balancing patient-centered care and clinical discretion with reimbursement decisions that may not provide coverage for patients throughout their care pathway.

Dehydrated Amniotic and Chorionic Allografts
(DHACAs)

Effectiveness:

20%

reduction in
30-day mortality

28%

reduction in risk of major amputation

9%

reduction in emergency department (ED) utilization

8%

reduction in
30-day readmission

DHACAs could reduce such amputation rates in cases up to

49%-85%

of amputations caused by these wounds are preventable

Wounds alone are associated with a 5 year mortality rate of

42%

30.5%

Efficient management of these wounds is therefore important to reduce medical costs and minimize long-term consequences associated with chronic wounds.